Daxor Corporation (DXR) support and resistance · P/E 6.5, rev $1.4M
Daxor Corporation (DXR) is a medical instruments & supplies company listed on US.
This page maps Daxor Corporation (DXR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported DXR revenue for 2011-12-31 was $1.4M. Net income was -$7.2M. Revenue was down 8.4% from 2010-12-31 to 2011-12-31. DXR currently screens at market cap $61.9M and trailing P/E 6.5.
DXR currently screens at market cap $61.9M and trailing P/E 6.5. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new DXR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the DXR quote page for the session range and the stock page for the full model.
Not investment advice.